Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PharmaLinkFHI, a clinical research organization managing Phase I-IV clinical trials, has acquired UK-based clinical research organization Matrix Contract Research.
Subscribe to our email newsletter
Both PharmaLink and Matrix Contract Research have been providing contract research services for biotechnology, pharmaceutical and device companies for approximately 10 years. The two companies have partnered together on numerous occasions on global clinical trial implementation and management.
Matrix currently provides core clinical operation services including project management, clinical monitoring and regulatory. These will now be augmented by PharmaLink’s US clinical resources and global e-data management and biostatistical groups to provide clients with full service, turnkey, global research services.
Richard Staub, president and CEO of PharmaLinkFHI, said: “The integration of Matrix with PharmaLink’s unique e-clinical service delivery model will allow us jointly to better serve our clients who require development services throughout the North America, western, central and eastern Europe including Russia.”